Immune-mediated necrotizing myopathy (IMNM) is a rare and aggressive form of idiopathic inflammatory myopathy, which is often associated with statin exposure and myositis-specific antibodies such as anti-HMGCR or anti-synthetase antibodies. Here, HMGCR is linked to myositis disease.